ProCOC: The prostate cancer outcomes cohort study
2008

Prostate Cancer Outcomes Cohort Study

Sample size: 1545 publication Evidence: moderate

Author Information

Author(s): Umbehr Martin, Kessler Thomas M, Sulser Tullio, Kristiansen Glen, Probst Nicole, Steurer Johann, Bachmann Lucas M

Primary Institution: University of Zurich, University Hospital of Zurich

Hypothesis

This study aims to improve understanding of treatment effects on quality of life and outcomes for men with localized prostate cancer.

Conclusion

The study will provide valuable insights into the prognosis and treatment options for men with localized prostate cancer.

Supporting Evidence

  • Prostate cancer is the most frequent newly diagnosed malignancy in men in the Western world.
  • The study aims to address unanswered questions about early diagnosis and treatment choices.
  • The study will set up a bio-bank for future research on prostate cancer.

Takeaway

This study is like a big project to help doctors understand how different treatments for prostate cancer affect men's lives.

Methodology

A prospective, multi-center cohort study collecting clinical data, quality of life assessments, and biological samples over at least ten years.

Limitations

The study may face challenges in patient recruitment and retention over the long duration.

Participant Demographics

Men with newly diagnosed localized prostate cancer in the Canton of Zurich, Switzerland.

Digital Object Identifier (DOI)

10.1186/1471-2490-8-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication